In addition to patients, healthcare providers also need to stay informed about the latest developments in medication options
Beghi E, Pupillo E, Bonito V, Buzzi P, Caponnetto C, Chi A, Corbo M, Giannini F, Inghilleri M, Bella VL, Logroscino G, Lorusso L, Lunetta C, Mazzini L, Messina P, Mora G, Perini M, Quadrelli ML, Silani V, Simone IL, Tremolizzo L
Perioperative IDH inhibition in treatment-naive IDH -mutant glioma: a pilot trial
Our commitment is to provide comprehensive care by guiding you through the options of Semaglutide, Ozempic, Wegovy, and Mounjaro, ensuring that your treatment plan is tailored to your specific health goals and needs
PMID 15290671